Stanley Druckenmiller Dumps Amazon And Alphabet While Loading Up On Commodities, Argentina And Biotech
Caris Life Sciences Inc CAI
$15.79
▼ -0.94%
($-0.15)
Open
$15.97
Prev Close
$15.94
Day Range
$15.64 – $16.33
52W Range
$14.19 – $42.50
Market Cap
$4.47B
Beta
0.28
EPS (TTM)
$-0.25
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2025-06-18 |
| Shares Out. | 282,680,000 |
| Website | carislifesciences.com/ ↗ |
| Phone | 18667718946 |
Caris Life Sciences Inc is a publicly traded company under the ticker symbol CAI on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
17 analysts (2026-05-01)
📰 Latest News for CAI
Caris Life Sciences Announces Publication Of A Caris‑Led Study In The Oncologist The Shows Its Lookback Program's Ability To Identify Previously-Profiled Patients Who Become Eligible For Newly Approved Targeted Therapies
Caris Life Sciences, Inc. (CAI) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Transcript : Caris Life Sciences, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10
Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene Panels
Caris Life Sciences : Submits Application to New York State Department of Health for Caris Assure Blood Based Testing Authorization
Citigroup Maintains Buy on Caris Life Sciences, Lowers Price Target to $28
Caris Life Sciences Submits Application To NYSDOH Clinical Laboratory Evaluation Program Seeking Authorization To Perform Caris Assure On Specimens Originating From New York State